Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Combine AOD-9604 CJC-1295 Synergy Dosing Timing: Protocol Comparison

Before committing to a combined AOD-9604 and CJC-1295 research protocol, understanding the differences between DAC and no-DAC formulations of CJC-1295 is essential. The table below compares the two primary approaches. Extended-Release Protocol CJC-1295 with DA

This comparison does not assign a generated winner or score.

  • Before committing to a combined AOD-9604 and CJC-1295 research protocol, understanding the differences between DAC and no-DAC formulations of CJC-1295 is essential. The table below compares the two primary approaches.
  • Extended-Release Protocol
  • CJC-1295 with DAC
  • 1–2 mg per week, divided into 2 doses
  • 250–500 mcg twice daily (morning fasted + evening 20–30 min post-CJC)
  • CJC evening (8–10 PM), AOD 20–30 min later + morning fasted
  • Store separately, never co-mix. Maleimide cross-linking risk
  • CJC amplifies nocturnal GH pulse; AOD captures elevated GH window for sustained lipolysis
  • Best for researchers prioritizing convenience and stable plasma levels. Fewer injections, lower protocol complexity
  • Pulsatile Protocol
  • CJC-1295 no-DAC (Mod GRF 1-29)
  • 100 mcg 3–4 times daily
  • 250–500 mcg 3–4 times daily, dosed simultaneously with CJC
  • Simultaneous dosing upon waking, pre-workout, before bed
  • Both peptides degrade within 30 min. Must dose together to align peaks
  • Both peptides peak simultaneously, creating sharp GH + lipolysis surges
  • Best for researchers mimicking natural pulsatile GH release. Requires more frequent dosing but tighter pharmacokinetic control
  • Hybrid Protocol
  • CJC-1295 with DAC + CJC no-DAC
  • DAC 1 mg weekly; no-DAC 100 mcg 2x daily on training days
  • 250–500 mcg twice daily, timed with no-DAC doses on training days
  • DAC provides baseline GH elevation; no-DAC + AOD timed around exercise
  • Requires 3 separate vials (DAC, no-DAC, AOD). Most complex reconstitution workflow
  • DAC sustains GH baseline; no-DAC + AOD create acute surges during metabolic windows
  • Best for advanced researchers willing to manage increased protocol complexity for maximum flexibility. Highest synergy potential but most demanding
More references

Related material